Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 614-345-5 | CAS number: 68155-40-8
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Additional information
2,2'(Octadec-9-enylimino)bisethanol CAS NO 25307-17-9 was tested in a bacterial reverse mutation assay () and was not mutagenic with or without S9 mix. It was also tested for mammalian cell gene mutation in the L5178Y TK +/- Mouse lymphoma assay and was not mutagenic. In addition it was tested in a Chromosomal aberration test in human lymphocytes in-vitro and was found to be not clastogenic. All tests were to current OECD/EU protocols carried out to GLP and with a clearly defined and described test substance. Based on this it can be concluded that 2,2'(Octadec-9-enylimino)bisethanol CAS NO 25307-17-9 would not be expected to have any genotoxic hazard to human health.
Short description of key information:
2,2'(Octadec-9-enylimino)bisethanol CAS NO 25307-17-9 was tested in three in-vitro genotoxicty studies to current protocol and carried out to GLP with well defined test substance. All three test were negative.
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
Based on the three negative in-vitro tests for genotoxicity of the read across substance 2,2'(Octadec-9-enylimino)bisethanol CAS NO 25307-17-9 does not require classification as a mutagen according to the European Union CLP/GHS criteria.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
